Price history
¥2,086Latest+308.2%
Drag across the chart to measure the move between two points.Delayed 15 minutes · monthly closing basis
Business overview
Recurring subjects
No threads yetThis company's filings have not been read yet. We are adding them progressively.
Companies sharing a theme
News
Key numbersShowing 8 of 20
PER
56.36How many years of earnings it would take to buy the stock. The market average is generally considered to be around 15.PBR
2.14How many times the company's net assets? Around 1x is generally considered a benchmark.ROE
3.8%Earning power. A figure above 10% is generally considered good.Dividend yield
0.0%The annual dividend as a percentage of the share price.Market capitalization
¥279bnShare price × number of shares. The value of the entire company.Equity ratio
76.3%The proportion of assets funded by money that does not have to be repaid.Operating margin
21.7%The percentage of revenue remaining from the company’s core business.Revenue growth (3 years)
7.4%The average annual growth in sales over the past three years.What to watch next
Progress and disclosure of the results of the share buyback through market purchases (acquisition period: 13 May 2026 to 30 September 2026; maximum 5,000,000 shares)
Through September 2026Impact MediumLikelihood Medium
Ramp-up of expanded facilities at the Amagasaki and Matsuyama plants and elsewhere, including the impact on production and shipments after completion of the second expansion phase and new facilities
Fiscal 2026, reflecting the post-completion ramp-upImpact MediumLikelihood Medium
Healthcare: progress in human-trial results for OS-1010 and quantification of expanded new-product adoption, including the number of adoptions and contribution to sales
Fiscal 2026 onward, depending on the next stage of the trialsImpact HighLikelihood Low
Materials such as ultrahigh-ion-conductivity polymers for all-solid-state batteries: consideration and development of a mass-production framework, including pilot facilities, and the presentation of milestones toward commercialization in 2030
Through 2030, with the short term focused on fleshing out the planImpact HighLikelihood Low
What to watch next
Who owns itTop holders total 40.9%
Listed holders 40.9%Everyone else 59.1%
The Master Trust Bank of Japan, Ltd. (Trust Account)11.19%
株式会社日本カストディ銀行 (Trust Account)7.33%
株式会社三菱UFJ銀行3.57%
株式会社福岡銀行3.35%
The Iyo Bank, Ltd.3.05%
Mizuho Bank, Ltd.2.73%
日本生命保険相互会社2.60%
Sompo Japan Insurance Inc.2.51%
2 other listed holders4.57%
| Holder | Ownership (%) |
|---|---|
| The Master Trust Bank of Japan, Ltd. (Trust Account) | 11.19 |
| 株式会社日本カストディ銀行 (Trust Account) | 7.33 |
| 株式会社三菱UFJ銀行 | 3.57 |
| 株式会社福岡銀行 | 3.35 |
| The Iyo Bank, Ltd. | 3.05 |
| Mizuho Bank, Ltd. | 2.73 |
| 日本生命保険相互会社 | 2.60 |
| Sompo Japan Insurance Inc. | 2.51 |
| 2 other listed holders | 4.57 |
This company's documents
Filings
Timely disclosures
- 2026-10-01Notice Regarding the Status of Share Repurchases and Completion of the Repurchase Program
- 2026-09-01Notice Regarding the Status of Share Repurchases
- 2026-08-07Notice Regarding Revisions to Earnings Forecasts and Dividend Forecast
- 2026-08-07Summary of Financial Results for the First Quarter of the Fiscal Year Ending March 2027 [Japanese GAAP] (Consolidated)
- 2026-08-03Notice Regarding the Status of Share Repurchases
- 2026-07-28Notice Regarding Completion of Payment for Disposal of Treasury Shares and Partial Forfeiture
- 2026-07-21Notice Regarding the Disposal of Treasury Shares as Restricted Stock Compensation
- 2026-07-02Notice Regarding the Status of Share Repurchases
19 more
- 2026-06-26Articles of Incorporation 2026/06/26
- 2026-06-04Notice of Convocation of the 171st Annual General Meeting of Shareholders: Other Matters Subject to Electronic Provision (Matters Not Included in the Delivered Document)
- 2026-06-04Notice of Convocation of the 171st Annual General Meeting of Shareholders
- 2026-06-02Notice Regarding the Status of Share Repurchases
- 2026-05-27Independent Officer Notification Form
- 2026-05-13Notice Regarding the Results of the Acquisition of Treasury Shares through an Off-Auction Purchase (ToSTNeT-3)
- 2026-05-12Notice Regarding the Purchase of Treasury Shares Through an Off-Auction Purchase (ToSTNeT-3)
- 2026-05-12Notice Regarding Personnel Changes
- 2026-05-12Summary of Financial Results for the Fiscal Year Ending March 2026 [Japanese GAAP] (Consolidated)
- 2026-05-12Notice Regarding the New Medium-Term Management Plan (Fiscal 2026–Fiscal 2030)
- 2026-05-12Notice Regarding the Decision on Matters Concerning the Acquisition of Treasury Shares
- 2026-05-12Notice Concerning Dividend from Surplus (Dividend Increase)
- 2026-05-12Notice Regarding the Discontinuation (Abolition) of the Policy for Responding to Large-Scale Purchases of the Company's Shares (Takeover Defense Measures)
- 2026-04-20Notice Regarding the Disposal of Treasury Shares as a Restricted Stock Incentive for the Employee Stock Ownership Plan
- 2026-04-16(Correction) Partial correction to the "Notice Concerning Personnel Changes"
- 2026-03-27Notice Regarding Personnel Changes
- 2026-03-23Notice Regarding the Introduction of a Restricted Stock Incentive Plan for the Employee Stock Ownership Association
- 2026-03-23Notice Regarding Personnel Changes
- 2026-03-13Notice Regarding Personnel Changes
Threads
- 2026-10-01Achieving ¥30 Billion in Operating Profit in FY2030 under the Ninth Medium-Term Management Plan “Transform Our Future 2030”
- 2026-09-01Shareholder returns and improved capital efficiency through share buybacks
- 2026-08-07Expanding Overseas Operations and Developing Overseas Production and R&D Bases
- 2026-08-07Expanding Synthetic Resin and Synthetic Rubber Offerings and Entering the Compounding Business
- 2026-08-07Developing the healthcare-related business into a third earnings pillar
- 2026-08-07Expansion of sales of pharmaceutical purification materials and active pharmaceutical ingredient intermediates, along with increased production capacity and enhanced specialized equipment
- 2026-08-07Stable Dividends Based on Earnings and Retained Earnings
- 2026-08-07Earnings Volatility from Market Product Prices and Competition
96 more
- 2026-08-07Growth in Functional Chemicals and New Record High Profit
- 2026-08-07Q1 2017: Sales Down, Operating Profit Up, Net Income Down Due to Foreign Exchange Losses
- 2026-08-07Uncertainty in Export and Earnings Conditions from Rising Raw Material and Fuel Prices
- 2026-08-07Impact of Lower Automobile Production in India on Epichlorohydrin Rubber Sales
- 2026-08-07Enhancing Sustainability Disclosure through Integrated Reporting
- 2026-08-07Functional Research and Human Trials for Plant-Based Lactic Acid Bacteria OS-1010
- 2026-08-07Strengthening the VHH Antibody Development and Contract Manufacturing Business
- 2026-07-28Introduction of a Restricted Stock Incentive Plan for the Employee Shareholding Association
- 2026-07-21Executive Compensation Linked to Consolidated Operating Profit and Individual Contributions
- 2026-06-25Developing into a Global Company for the Next 100 Years
- 2026-06-25Creating High Value-Added Products through Original Manufacturing and R&D
- 2026-06-25Restructuring and Further Strengthening Existing Businesses
- 2026-06-25A Stable, Efficient Production System for High-Mix, Low-Volume Manufacturing Integrated with IoT
- 2026-06-25Strengthening Legal Compliance, Internal Controls and Corporate Governance
- 2026-06-25Organizational Risk Management through Crisis Management Rules and the RC Committee
- 2026-06-25Information Provision, Evaluation Periods and Defensive Measures for Large-Scale Purchases Resulting in a 20% or Greater Voting Interest
- 2026-06-25Overseas Laws and Regulations, Political and Economic Conditions, and Social Unrest
- 2026-06-25R&D Expenses of ¥1,485 million
- 2026-06-25Overseas Sales Network Spanning Asia, Europe and North America
- 2026-06-25Daiso Chemical’s Merger with Impex and Changes in the Consolidated Subsidiary Structure
- 2026-06-25Reviewing the Rationale for Cross-Shareholdings and Reducing Holdings Without Sufficient Rationale
- 2026-06-25¥2,434 Million of Capital Expenditure Focused on Rationalization Investments
- 2026-06-25Business-Unit-Led Market-In Product Development and Early Commercialization
- 2026-06-25Corporate Culture and Organizational Reform and Renewal of Business Systems and HR制度
- 2026-06-25Development of Ultra-High Ionic Conductivity Polymers for All-Solid-State Batteries
- 2026-06-25Elite Advanced Polymers, Inc. Becomes a Consolidated Subsidiary
- 2026-06-25Target of a 30% Reduction in CO2 Emissions by Fiscal 2030
- 2026-06-25Target of at Least 5.6% Female Managers
- 2026-06-25Addressing Climate Change through High-Efficiency Equipment and Production Process Rationalization
- 2026-06-25Strengthening Existing Businesses, New Products and Sustainability under the Eighth Medium-Term Management Plan “Shape the Future-2025”
- 2026-06-25Achieving Carbon Neutrality by FY2050
- 2026-06-25Business Continuity Risk from the Increase and Sophistication of Cyberattacks
- 2026-06-25Adoption of Lease Accounting Standards from the Beginning of FY2028
- 2026-06-25Entry into the Polymer Gel Market for Nucleic Acid and Peptide Drugs
- 2026-06-04Creating New Products and Businesses and Bringing Global Niche-Top Products to Market Early
- 2026-05-27External Oversight Structure with 3 Outside Directors and 2 Outside Audit & Supervisory Board Members
- 2026-05-12Expanding Functional Chemicals Sales in Europe and North America and Acquiring New Pharmaceutical Customers
- 2026-05-12Declining exports due to China's slowing growth
- 2026-05-12Cash Allocation and Investor Engagement Focused on Cost of Capital and Share Price
- 2025-11-10Strengthening Chlor-Alkali Supply and Logistics Functions
- 2025-11-10Environmental Compatibility through Responsible Care, ISO, Resource Conservation and Energy Efficiency
- 2025-11-10Supply Interruptions Caused by Supplier Accidents, Quality Defects or Bankruptcy
- 2025-11-10Impact of Product Defects on Earnings, Financial Condition and Social Reputation
- 2025-11-10Business disruptions caused by intellectual property disputes and infringement
- 2025-11-10Material Litigation with Business Partners and Third Parties
- 2025-11-10Production Interruptions Caused by Natural Disasters and Manufacturing Equipment Accidents
- 2025-11-10Compensation Costs and Plant Shutdowns Resulting from Environmental Incidents
- 2025-11-10Three-Segment Structure of Basic Chemicals, Functional Chemicals and Housing Equipment and Other Businesses
- 2025-11-10Failure to Achieve Expected Results from Acquisitions and Capital Alliances and Goodwill Impairment
- 2025-11-10Customer Credit Risk Relating to Trade Receivables
- 2025-11-10Managing Funding and Payment Risks by Maintaining Sufficient Liquidity
- 2025-11-10Market Price Fluctuation Risk for Securities and Investment Securities
- 2025-11-10Stagnation of economic activity and declining demand due to the spread of COVID-19
- 2025-11-10Production Interruption Risk from the Spread of Infectious Diseases among Employees
- 2025-11-10Climate Change Risk Assessment under 1.5–2°C and 4°C Scenarios
- 2025-11-10Improving the Workplace Environment and Employee Engagement through Headquarters Relocation
- 2024-11-11Change in Accounting Auditor from EY ShinNihon to PwC Japan after 55 Years of Audits
- 2024-11-11Development and Demonstration of Trace Metal Adsorbents for Resource Recycling
- 2024-11-11Five-for-One Share Split and Change in the Number of Authorized Shares
- 2024-06-28Adoption of Tax Effect Accounting Guidance from the Beginning of FY2025
- 2024-06-28Changes in Positions Including the Head of the Corporate Strategy Division
- 2024-06-28Recognition of a ¥252 Million Loss on Valuation of Shares in Affiliates
- 2024-06-28Independent Nomination and Compensation and Development of Next-Generation Management Talent through the Nomination and Compensation Committee
- 2024-06-28Coverage of Damages and Litigation Costs through Directors and Officers Liability Insurance
- 2024-02-13Addressing Climate-Related Information through TCFD and GHG Emissions Measurement
- 2024-02-13PBR Above 2x Reflecting the Market’s Evaluation of the Healthcare Growth Strategy
- 2023-11-10Building a New Research Facility and Conducting Joint Research with Customers
- 2023-11-10Three Basic Policies under the New Medium-Term Management Plan and Postponement of Its Announcement Due to the Mizushima Plant Incident
- 2023-06-30Using Retained Earnings for R&D, Capital Expenditure and M&A
- 2023-06-30Increase in Shares and Capital from Exercise of Share Acquisition Rights Attached to Bonds
- 2023-06-30Financing through the Issuance of the Sixth Series of Unsecured Convertible Bonds with Share Acquisition Rights
- 2023-06-30Nitto Kako Becomes an Equity-Method Affiliate
- 2023-06-30Business Platform, Development and Organizational Reform under the 7th Medium-Term Management Plan “EMPOWER THE NEXT-22”
- 2023-06-30Development of Materials for Next-Generation 5G and 6G Communications Technologies
- 2023-06-30Strengthening SDG Initiatives through the Establishment of a Sustainability Committee
- 2023-02-13Planned adoption of the accounting standard for revenue recognition
- 2023-02-13Accounting Estimates for the Impact of COVID-19
- 2022-02-09Building a Stable Supply Structure through Integration of Electrolysis Facilities at the Kitakyushu Plant
- 2022-02-09Joint Development and Mass-Production Supply Structure for Semi-Solid Batteries Using Specialty Polyethers
- 2021-08-10Adoption of Fair Value Measurement Accounting Standards from the Beginning of FY2022
- 2021-06-30Abolition of the Officer Retirement Benefit System and Payment of Benefits Upon Abolition
- 2021-06-30Consolidation of Building Materials and Lifestyle Products Businesses and Merger with Okayama Kasei
- 2021-06-30Accounting Standard for Disclosure of Accounting Estimates
- 2021-02-08The New Growth Stage under the Sixth Medium-Term Management Plan “BRIGHT-2020”
- 2019-06-28Using Derivatives Solely for Underlying Business Needs and Prohibiting Speculative Trading
- 2019-06-28Strengthening Management of Affiliates and Overseas Subsidiaries and Building an Agile Organization
- 2019-06-28Independence Criteria for Outside Director and Officer Candidates
- 2019-06-28Coordination among the President’s Internal Audit Office, Audit & Supervisory Board Members and the Accounting Auditor
- 2018-11-07Growing Overseas Demand for Electrodes Used in Copper Foil Production
- 2018-06-29Business Expansion and Strengthening Under the Five-Year Plan “NEXT FRONTIER-100”
- 2018-06-29Integrating Asian Sales Bases and Concentrating Management Resources in Overseas Subsidiaries
- 2018-06-29Expansion of Silica Gel Production Facilities
- 2018-06-29Construction of New Allyl Resin Production Facilities
- 2018-02-13Acquisition of Shiseido Mirai Chemical Technology and Transfer of the Chromatography Business
- 2017-11-085-for-1 Share Consolidation and Change in Trading Unit
- 2017-02-13Adoption of the Implementation Guidance on Recoverability of Deferred Tax Assets